Hartree Partners’s CME Group CME Stock Holding History

Hartree Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20,000	Closed	-$2.92M	–	27
2017 Q4	$2.92M	Hold	20,000	–	–	3.75%	7
2017 Q3	$2.71M	Sell	20,000 -368	-2%	-$46.5K	4.56%	6
2017 Q2	$2.55M	Buy	20,368 +368	+2%	+$44K	4.83%	3
2017 Q1	$2.38M	Hold	20,000	–	–	2.64%	8
2016 Q4	$2.31M	Buy	+20,000	New	+$2.23M	4.74%	5

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Hartree Partners's CME Position: Q1 2018 in Review

Hartree Partners sold out of CME Group (CME) in Q1 2018, closing a stake of 20,000 shares — an estimated $2.92M sold.

Hartree Partners first reported a position in CME in Q4 2016 and held it in 5 quarters. The position peaked at $2.92M in Q4 2017. 899 funds tracked by Wall St. Rank hold CME as of Q1 2018.

Hartree Partners reported no remaining CME Group position as of Q1 2018 after selling out during the quarter.
Hartree Partners sold 20,000 CME Group shares in Q1 2018, an estimated $2.92M.
Hartree Partners first reported a position in CME Group in Q4 2016 and held it in 5 quarters.
Hartree Partners's CME Group position peaked at $2.92M in Q4 2017.
899 funds tracked by Wall St. Rank held CME Group as of Q1 2018.

Based on Hartree Partners's 13F filing for Q1 2018, filed 3 May 2018.